Pages that link to "Glossary:TAG-00041-Ame-run"

The following pages link to Glossary:TAG-00041-Ame-run:

Displaying 32 items.

• Glossary (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40c-001 (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 63 g Absatz 3 (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 11 - 12 (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 2 (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.53 (c) (vi) (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 2.5 (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.53 (c) (vi) - (vii) (← links)
• Reference:WMA Declaration of Helsinki 2024 Paragraph 23 - Amendment approval (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Protocol Amendment (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 3.2 - Responsibility (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.4 - Amendment (← links)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 7.5.1 (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40c-002 (← links)
• Reference:DEU KPBV - Klinische Prüfung-Bewertungsverfahren-Verordnung 31-Jan-2022 § 9 (← links)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 54 (← links)
• Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 2.4 (← links)
• Reference:DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 6 6.3 (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 11 (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 22-23 (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 24 (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 25 (← links)
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.110 (b) (2) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.30 (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.31 (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.35 (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 8 (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.4 - immediate hazard (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.30 (b) (ii) (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 5 (5) (← links)
• Reference:USA 45 CFR Part 160 09-Apr-2025 § 164.526 (← links)